Related Experiment Video
Updated: May 23, 2025

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
Published on: September 27, 2024
Vascular function and arterial stiffness in multisystem inflammatory syndrome in children with Covid-19
Alireza Ahmadi1, Mohammad Reza Sabri1, Mehdi Ghaderian1
1Pediatric Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.
Insights
Children with MIS-C show signs of arterial stiffness and endothelial dysfunction, indicated by higher pulse pressure and lower flow-mediated dilation (FMD). Early cardiovascular monitoring is crucial for these patients.
Area of Science:
- Pediatric Cardiology
- Infectious Diseases
- Vascular Biology
Background:
- Multisystem Inflammatory Syndrome in Children (MIS-C) is a severe post-COVID-19 complication.
- MIS-C can lead to significant cardiovascular issues, including endothelial dysfunction and arterial stiffness.
Purpose of the Study:
- To investigate cardiovascular health in children diagnosed with MIS-C.
- To compare vascular parameters between MIS-C patients and healthy controls.
Main Methods:
- A cohort study involving 59 children with MIS-C and 59 healthy controls.
- Non-invasive assessment of brachial artery flow-mediated dilation (FMD), aortic distensibility (AD), and aortic strain (AS).
Main Results:
- MIS-C patients exhibited higher systolic blood pressure and borderline elevated pulse pressure.
- Lower FMD, AS, and AD values were observed in the MIS-C group, though not statistically significant.
- Systolic blood pressure was significantly higher in the MIS-C group (P = 0.012).
Conclusions:
- Children with MIS-C display indicators of arterial stiffness and endothelial dysfunction.
- Flow-mediated dilation (FMD) may be a more sensitive marker for endothelial dysfunction in MIS-C.
- Emphasizes the need for vigilant cardiovascular assessment and monitoring in MIS-C patients due to long-term risks.
Background:
Multisystem Inflammatory Syndrome in Children (MIS-C) is a rare but severe condition that can develop in children who have had COVID-19. It can lead to cardiovascular complications, potentially caused by endothelial dysfunction and arterial stiffness.
Methods:
This study aimed to investigate the cardiovascular health of children with MIS-C compared to healthy controls. Fifty-nine children with MIS-C and fifty-nine healthy individuals were included in this cohort study. Non-invasive techniques were employed to measure the brachial artery's flow-mediated dilation (FMD), aortic distensibility (AD), and aortic strain (AS).
Results:
The MIS-C group demonstrated significantly higher systolic blood pressure (P = 0.012), with a mean of 100.2 (10.1) mmHg compared to 95.3 (9.6) mmHg in the healthy group. The relative risk (RR) for elevated pulse pressure in the MIS-C group was borderline higher than in the healthy group (RR 95% CI: 1.06 [1.01-1.14]; P = 0.046). However, FMD, AS, and AD values were lower in the MIS-C group, with means of 13.6 (8.9), 10.4 (4.1), and 15.5 (2.7), respectively, although no significant differences were observed (P > 0.05).
Conclusion:
Children with MIS-C exhibited higher pulse pressure, indicating potential arterial stiffness. They also showed lower FMD, suggesting endothelial dysfunction. FMD appears to be a more reliable indicator of endothelial dysfunction in MIS-C patients compared to aortic strain. These findings underscore the importance of early assessment and monitoring of cardiovascular complications in MIS-C patients. Endothelial dysfunction and arterial stiffness are well-established risk factors for future cardiovascular events.
Related Concept Videos
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Inflammatory Response I: Vascular and Cellular
Vascular Spasm
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...

